Transforming growth factor-beta-1 variants are not associated with chronic nonalcoholic pancreatitis

Pancreatology

Volumn 5, Issue 1, 2005, Pages 75-80

  Böhm, Kerstin ^a   Teich, Niels ^a   Hoffmeister, Albrecht ^a   Mössner, Joachim ^a   Keim, Volker ^a   Bödeker, Hans ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Chronic pancreatitis; Polymorphism; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC PANCREATITIS; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 18744381581     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000084829     Document Type: Article

References (37)

1. Klöppel G, Maillet B: The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis. Virchows Archiv 1992;420:1-4.
2. Ikejiri N: The vitamin A-storing cells in human and rat pancreas. Kurume Med J 1990;37:7-81.
3. Apte MW, Haber PS, Applegate TL, Norton ID, McCaughan GW, Kortsen MA, Pirola RC, Wilson JS: Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture. Gut 1998;43:128-133.
4. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Berger H, Grünert A, Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-432.
5. Schneider E, Schmid-Kotsas A, Zhao J, Weidenbach H, Schmid RM, Menke A, Adler G, Waltenberger J, Grünert A, Bachem MG: Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol 2001;281:C532-C543.
6. Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, Grünert A, Bachem MG: Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: Implicatiions in pathogenesis of pancreatic fibrosis. Lab Invest 2000;80:47-55.
7. Haber PS, Keogh GW, Apte M, Moran CS, Stewart NL, Crawford DHG, Pirola RC, McCaughan GW, Ramm GA, Wilson JS: Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999;155:1087-1095.
8. Lee MS, Gu D, Feng L, Curriden S, Arnush M, Krahl T, Gurushantgaiah D, Wilson C, Loskutoff DL, Fox H, Sarvetnick N: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β1. Am J Pathol 1995;147:42-52.
9. Vogelmann R, Ruf D, Wagner M, Adler G, Menke A: Effects of fibrogenetic mediators on the development of pancreatic fibrosis in a TGF-β1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 2001;280:G164-G172.
10. Shek F WS, Benyon RC, Walker FM, McCrudden PR, Pender SLF, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP: Expression of transforming-growth-factor-β1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 2002;160:1787-1798.
11. Bachem MG, Schmid-Kotsas A, Kadlec N, Kandenwein J, Schmid R, Menke A, Adler G, Siech H, Grünert A: An antisense oligonucleotide binding to the promoter region of the TGFβ1 gene reduces autocrine stimulated collagen type I synthesis of cultured pancreatic stellate cells. Pancreas 1999;19:A414.
12. Kandenwein J, Schmid-Kotsas A, Menke A, Siech M, Adler G, Grunert A, Bachem M: Transforming-growth-factor-β1 is involved in autocrine stimulated matrix synthesis of pancreatic stellate cells. Gastroenterology 1999;116:G4816.
13. Kennedy RH, Bockmann DE, Uscanga L, Choux R, Grimaud JA, Sarles H: Pancreatic extracellular alterations in chronic pancreatitis. Pancreas 1987;2:61-72.
14. Kazbay K, Tarnasky PR, Hawes RH, Cotton PB: Increased transforming growth factor-β in pure pancreatic juice in pancreatitis. Pancreas 2000;22:193-195.
15. Menke A, Adler G: TGF-β1 induced fibrogenesis of the pancreas. Int J Gastrointest Cancer 2002;31:41-46.
16. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD: Genetic control of the circulating concentrations of transforming growth factor type β1. Hum Mol Genet 1999;8:93-97.
17. Kim SJ, Wagner S, Liu F, O'Reilly MA, Robbins PD, Green MR: Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-3. Nature 1992;358:331-334.
18. Grainger DJ, Metcalfe JC: Transforming growth factor-β and cardiovascular protection; in Rubanyi GM, Dzau VJ (eds): The Endothelium in Clinical Practice. Source and Traget of Novel Therapies. New York, Dekker, 1997, pp 203-242.
19. Randall L, Hardy SJ: Unity in function in the absence of consensus in sequence: Role of leader peptides in export. Science 1989;243:1156-1159.
20. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y: Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-2787.
21. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnot PJ, Hutchinson IV: Genotypic variation in the transforming growth factor β1 production, fibrotic lung disease and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020.
22. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
23. Teich N, Bauer N, Mössner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: Identification of further trypsinogen variants. Am Gastroenterol 2002;97:341-346.
24. Perneger TV: What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238.
25. Teich N, Mössner J, Keim V: Mutations of the cationic trypsinogen in hereditary pancreatitis. Human Mutat 199812:39-43.
26. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-216.
27. Witt H, Luck W, Becker M, Böhmig M, Kage A, Truninger K, Ammann RW, O'Reilly D, Kingsnorth A, Schulz HU, Halangk W, Kielstein V, Knoefel WT, Teich N, Keim V: Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001;285:2716-2717.
28. Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PVJ, Singh L: Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002;39:347-351.
29. Mews P, Phillips P, Fahmy R, Korsten M, Pirola R, Wilson J, Apte M: Pancreatic stellate cells respond to inflammatory cytokines: Potential role in chronic pancreatitis. Gut 2002;50:535-541.
30. Neuschwander-Tetri BA, Burton FR, Presti MP, Britton R, Janney CG, Garvin PR, Brunt EM, Galvin N, Poulos JE: Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci 2000;45:665-674.
31. Dunning AM, Ellis PD, McBrideS, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah RN, Easton DF, Ponder BA, Metcalfe JC: A transforming-growth-factor-β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003;63:2610-2615.
32. Ohtsuka T, Yamakage A, Yamazaki S: The polymorphism of transforming growth factor β1 gene in Japanese patients with systemic sclerosis. Br J Dermatol 2002;147:458-463.
33. Pulleyn LJ, Newton R, Adcock IM, Barnes PJ: TGFβ1 allele association with asthma severity. Hum Genet 2001;109:623-627.
34. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV: TGF-β1 genotype and accelerated decline in lung function in patients with cystic fibrosis. Thorax 2000;55:459-462.
35. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM: Association of polymorphisms of the transforming-growth-factor-β1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 2002;316:83-94.
36. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O: Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure (Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study). Hypertension 1996;28:881-887.
37. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Graininger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffrey S, Heathcote K: Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin Sci 1998;95:659-667.